Enphys Acquisition Corp.
NFYS · NYSE
12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | -0.85 | 0.03 | 0.00 |
| FCF Yield | 1.46% | -0.10% | -0.14% |
| EV / EBITDA | 26.75 | -25.96 | -580.50 |
| Quality | |||
| ROIC | -0.79% | 2.42% | -0.21% |
| Gross Margin | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.41 | -0.03 | -0.29 |
| Growth | |||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% |
| Free Cash Flow Growth | 1,465.06% | 24.95% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | 0.03 | 0.02 | 1.14 |
| Interest Coverage | -34.24 | 0.00 | 0.00 |
| Efficiency | |||
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 |